Previous 10 | Next 10 |
2023-04-20 22:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-19 17:54:02 ET Summary We maintain a buy rating on Axsome Therapeutics, Inc.: despite potential clinical/regulatory risks, Axsome's solid cash runway and Auvelity's initial launch progress support a positive outlook. The key catalysts in the near future include data from P...
2023-04-19 12:15:34 ET BlackRock does not expect the Federal Reserve to cut rates in 2023 despite some degree of optimism in the market. As a result, the firm warned of potential volatility during the rest of the year, advising investors to consider a more "granular" approach to equities. ...
2023-04-19 07:34:21 ET Money managers are the most Overweight bonds compared to equities since the Financial Crisis, according to the latest survey from BofA Securities. The April Fund Manager Survey of 286 panelists with $728B in assets under management was the "most bearish" of t...
2023-04-18 19:01:14 ET Summary Galecto (GLTO) is a clinical-stage biopharmaceutical company focused on small-molecule antifibrotic and anticancer agents. GLTO has upcoming data readouts in 2023 that could add more evidence to the potential of their therapies, including top-line IP...
2023-04-18 01:41:44 ET Summary Morphic Holding is developing innovative oral integrin therapies with lead candidate MORF-057 in phase 2. MORF-057 targets α4β7, a highly validated mechanism of action similar to Entyvio, which generated ~4$Bn in sales during 2021. ...
2023-04-18 01:35:00 ET Summary For the third month in a row, mutual fund investors were net purchasers of fund assets, injecting $286.4 billion into conventional funds for March. Fixed income funds (-$23.3 billion) witnessed net outflows for the first month in three, while money m...
2023-04-17 10:30:00 ET Summary The joint stock-bond rally this year has put renewed focus on portfolio construction approaches. We think a new macro regime needs a new approach. U.S. stocks rose last week but lost steam on Friday on the market partly pricing out potential rate cut...
2023-04-17 07:00:49 ET Summary Merck demonstrates its dominant position with its bold move to acquire Prometheus Biosciences for nearly $11 billion, offering a premium of over 75% above RXDX's Friday closing price. Merck faces a critical challenge in reducing its dependence on Key...
2023-04-16 01:22:24 ET Summary Regeneron's Dupixent reported a 30% reduction in COPD exacerbation at week 52, while ensifentrine reported a 36% and 42% reduction in the ENHANCE-1 and ENHANCE-2 trials, respectively. Ensifentrine's broader inclusion criteria and lower cost as a smal...
News, Short Squeeze, Breakout and More Instantly...
SPDR Select Sector Fund - Health Care Company Name:
XLV Stock Symbol:
NYSE Market:
2024-07-09 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-29 11:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...